Knee Bursitis Market Share, Trends And Growth By 2034


Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Current Size and Annual Growth Rate of the Knee Bursitis Market?
The knee bursitis market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.86 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to an aging population, increased participation in sports and physical activities, improved diagnostic techniques, improved access to healthcare services, and education programs for healthcare professionals and patients.

The knee bursitis market size is expected to see strong growth in the next few years. It will grow to " $3.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increased awareness campaigns about prevention and management, growth in disposable income, rising healthcare expenditure, and increasing awareness and diagnosis of knee bursitis. Major trends in the forecast period include advancements in diagnostic techniques, the development of novel therapies, advancements in research and development activities, and telemedicine and remote monitoring.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

What Are the Primary Factors Driving the Knee Bursitis Market?
The increasing prevalence of bone-related diseases is expected to propel the growth of the knee bursitis market going forward. Bone-related diseases encompass conditions such as osteoporosis, arthritis, and bone cancer, affecting the structure, strength, and function of the skeletal system. The increasing prevalence of bone-related diseases is attributed to factors such as aging populations, sedentary lifestyles, poor nutrition, and environmental changes. Bone-related diseases such as osteoarthritis and rheumatoid arthritis can lead to knee bursitis by causing inflammation and excessive pressure on the knee bursa. This inflammation results in pain, swelling, and reduced joint function. For instance, in September 2022, a report by Healthy Bones Australia, an Australia-based non-profit organization, projected that in 2022, Australia is estimated to have 6.2 million individuals aged 50 and above suffering from osteoporosis or osteopenia. This calculation is based on the fact that 22% have osteoporosis and 78% have osteopenia among the 4.74 million Australians with poor bone health. Therefore, the increasing prevalence of bone-related retailers is driving the growth of the knee bursitis market.

How Is the Knee Bursitis Market Categorized Based on Key Segments?
The knee bursitismarket covered in this report is segmented –

1) By Diagnosis: Imaging Test; Other Diagnosis Tests
2) By Treatment: Medication; Therapy; Surgery; Other Treatments
3) By End User: Hospitals And Clinics; Diagnostic Centers; Research Centers; Academic Institutes; Other End Users

Subsegments:
1) By Imaging Test: X-Ray; MRI (Magnetic Resonance Imaging); Ultrasound
2) By Other Diagnosis Tests: Physical Examination; Aspiration Of Joint Fluid; Blood Tests




Who Are the Major Companies Operating in the Knee Bursitis Market?
Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Get the detailed knee bursitis market report today
https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Region Holds the Largest Share of the Knee Bursitis Market?
North America was the largest region in the knee bursitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more